Showing results (171-180 of 398) with videos related to
Sort By:
Pageof 40
Behavioural Pharmacology|April 23, 2011
Disruptive effects of the prototypical cannabinoid Δ⁹-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in ratsLjiljana Sokolic, Leonora E Long, Glenn E Hunt, et al.Addiction Biology|October 15, 2011
Mephedrone (4-methylmethcathinone, 'meow'): acute behavioural effects and distribution of Fos expression in adolescent ratsCraig P Motbey, Glenn E Hunt, Michael T Bowen, et al.Psychopharmacology|March 13, 2015
WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist actionCallum Hicks, Linnet Ramos, Tristan A Reekie, et al.Harm Reduction Journal|July 4, 2026
Patterns, motivations, and healthcare experiences of medical cannabis use among gender and sexuality diverse people in Australia: findings from the Cannabis as Medicine Survey 2022 (CAMS-22)Benjamin T Trevitt, Sasha Bailey, Llewelyn Mills, et al.Neuropharmacology|March 8, 2003
Regional differences in naloxone modulation of Delta(9)-THC induced Fos expression in rat brainK V Allen, I S McGregor, G E Hunt, et al.The International Journal of Neuropsychopharmacology|February 19, 2011
Differential behavioural and neurochemical outcomes from chronic paroxetine treatment in adolescent and adult rats: a model of adverse antidepressant effects in human adolescents?Emily Karanges, Kong M Li, Craig Motbey, et al.Neuroscience|March 27, 2007
A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy")M R Thompson, P D Callaghan, G E Hunt, et al.The Medical Journal of Australia|August 11, 2018
Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS-16)Nicholas Lintzeris, Jessica Driels, Natalie Elias, et al.Brain Research|January 9, 1997
Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulationH Q Lin, D M Jackson, D M Atrens, et al.Nature and Science of Sleep|April 24, 2023
Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 SurveyAnastasia Suraev, Llewellyn Mills, Sarah V Abelev, et al.Pageof 40